| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 127.710 | 125.737 | 164.772 | 92.156 | 106.470 | 130.850 | 126.573 | 150.032 | 163.523 | 209.263 |
| Total Income - EUR | 129.066 | 125.915 | 166.506 | 92.511 | 106.822 | 132.350 | 126.905 | 154.822 | 182.815 | 209.645 |
| Total Expenses - EUR | 125.136 | 118.695 | 152.246 | 98.974 | 127.196 | 129.740 | 127.744 | 138.146 | 154.366 | 203.822 |
| Gross Profit/Loss - EUR | 3.930 | 7.220 | 14.260 | -6.463 | -20.373 | 2.611 | -839 | 16.676 | 28.449 | 5.823 |
| Net Profit/Loss - EUR | 2.057 | 5.442 | 12.651 | -7.390 | -21.432 | 1.398 | -2.109 | 15.157 | 26.836 | 1.215 |
| Employees | 4 | 5 | 5 | 5 | 6 | 6 | 5 | 4 | 4 | 5 |
Check the financial reports for the company - Dacrivet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.004 | 13.558 | 6.974 | 11.498 | 6.153 | 3.756 | 456 | 582 | 1.572 | 4.205 |
| Current Assets | 53.523 | 57.260 | 49.916 | 66.143 | 77.979 | 89.593 | 94.262 | 97.135 | 111.208 | 83.900 |
| Inventories | 39.702 | 48.080 | 41.476 | 54.085 | 62.868 | 62.325 | 71.994 | 79.409 | 80.011 | 58.262 |
| Receivables | 5.717 | 6.348 | 6.387 | 8.059 | 8.477 | 11.896 | 14.556 | 10.715 | 16.734 | 12.159 |
| Cash | 8.105 | 2.832 | 2.053 | 3.999 | 6.634 | 15.372 | 7.712 | 7.011 | 14.463 | 13.479 |
| Shareholders Funds | -1.780 | 3.680 | 16.271 | 8.582 | -13.016 | -11.371 | -13.069 | 2.047 | 28.877 | 29.930 |
| Social Capital | 45 | 45 | 46 | 45 | 44 | 43 | 202 | 203 | 202 | 201 |
| Debts | 77.308 | 67.137 | 40.620 | 67.983 | 96.435 | 104.357 | 107.760 | 95.670 | 83.903 | 58.175 |
| Income in Advance | 0 | 0 | 0 | 1.077 | 713 | 364 | 27 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Dacrivet Srl